Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study

BACKGROUND: In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosphatemia after an equivalent dosage of FDI had not been assessed prospectively. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Emrich, I. E., Lizzi, F., Siegel, J. D., Seiler-Mussler, S., Ukena, C., Kaddu-Mulindwa, D., D’Amelio, R., Wagenpfeil, S., Brandenburg, V. M., Böhm, M., Fliser, D., Heine, G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359262/
https://www.ncbi.nlm.nih.gov/pubmed/32654663
http://dx.doi.org/10.1186/s12916-020-01643-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359262/
https://www.ncbi.nlm.nih.gov/pubmed/32654663
http://dx.doi.org/10.1186/s12916-020-01643-5

Ejemplares similares